News from infectious disease research institute (idri)

Mar 24, 2014, 08:00 ET
IDRI scientists work toward discovering new, faster-acting drugs to combat tuberculosis.  (PRNewsFoto/Infectious Disease Research Institute (IDRI))

IDRI Receives $3.4 Million Grant Extension For TB Drug Discovery

IDRI's drug discovery efforts continue to grow with a recently awarded grant extension of $3.4 million from the Bill & Melinda Gates...

Jul 25, 2013, 09:30 ET
IDRI logo.  (PRNewsFoto/Infectious Disease Research Institute (IDRI))

IDRI and Zydus Sign Agreement for Development of IDRI's Vaccine Candidate for Visceral Leishmaniasis (Kala-Azar)

In a unique partnership, Zydus, India's fourth largest healthcare group and an innovation-led global healthcare provider, and IDRI, a...

Apr 17, 2013, 14:51 ET
IDRI logo.  (PRNewsFoto/Infectious Disease Research Institute (IDRI))

IDRI and Medicago Report Positive Results for Phase I Clinical Trial for an H5N1 Vaccine

- All three configurations of adjuvant and route of administration exceeded the three CHMP criteria- IDRI (Infectious Disease Research...

Apr 09, 2013, 07:00 ET
IDRI logo.  (PRNewsFoto/Infectious Disease Research Institute (IDRI))

IDRI and Medicago to present data at the World Vaccine Congress

IDRI (Infectious Disease Research Institute), a Seattle-based non-profit research organization that is a leading developer of adjuvants used...

Jan 24, 2013, 08:30 ET
IDRI logo.  (PRNewsFoto/Infectious Disease Research Institute (IDRI))

IDRI e OrangeLife registram diagnóstico rápido da lepra para uso no Brasil

O IDRI (Infectious Disease Research Institute -- Instituto de Pesquisa de Doenças Infecciosas), em conjunto com a OrangeLife, empresa...

Jan 24, 2013, 08:30 ET
IDRI logo.  (PRNewsFoto/Infectious Disease Research Institute (IDRI))

IDRI And OrangeLife Register Rapid Diagnostic For Leprosy For Use In Brazil

Marking Progress in Advance of World Leprosy Day, Observed Jan. 27  IDRI (Infectious Disease Research Institute), in conjunction with...

Aug 22, 2012, 10:00 ET
IDRI logo.  (PRNewsFoto/Infectious Disease Research Institute (IDRI))

As Tuberculosis Grows More Difficult to Control, Vaccine Candidate to Prevent Disease Enters Clinical Testing

Phase I study in Lenexa, KS, of novel vaccine targeting TB virulence and latency ROCKVILLE, Md. and SEATTLE, Aug. 22, 2012...

Aug 16, 2012, 04:00 ET
IDRI logo.  (PRNewsFoto/Infectious Disease Research Institute (IDRI))

IDRI and Medicago Announce FDA Authorization to Initiate a Phase 1 Clinical Trial for an H5N1 Vaccine with GLA Adjuvant

The Infectious Disease Research Institute (IDRI), a Seattle-based non-profit research organization that is a leading developer of adjuvants used...

May 30, 2012, 13:38 ET
IDRI logo.  (PRNewsFoto/Infectious Disease Research Institute (IDRI))

IDRI Signs Lease with Alexandria Real Estate Equities, Inc. for New Seattle Headquarters

The Infectious Disease Research Institute (IDRI) has officially signed a new lease in Seattle's South Lake Union neighborhood with long-time real...

May 09, 2012, 10:00 ET
IDRI logo.  (PRNewsFoto/Infectious Disease Research Institute (IDRI))

Aeras and IDRI Sign Agreement to Jointly Develop Novel Tuberculosis Vaccine

First Phase I study of vaccine candidate planned for this year Aeras and the Infectious Disease Research Institute (IDRI) announce today a...

Mar 08, 2012, 06:00 ET
IDRI logo.  (PRNewsFoto/Infectious Disease Research Institute (IDRI))

IDRI Quest for Leprosy Vaccine Closer to Reality With Help of Million Dollar Grant

Elimination campaign against ancient, yet prevalent disease, receives critical funding from RHSC Research and Data Institute Leprosy,...

Feb 22, 2012, 19:21 ET
IDRI logo.  (PRNewsFoto/Infectious Disease Research Institute (IDRI))

First Vaccine Against Fatal Visceral Leishmaniasis Enters Clinical Trial

As disease expands global reach, Infectious Disease Research Institute teams up with India to target most deadly form of leishmaniasis...

Jan 31, 2012, 14:28 ET

IDRI Supports the First Phase 1 Human Hookworm Vaccine Clinical Trial

The Infectious Disease Research Institute (IDRI) announced its technical support of the Sabin Vaccine Institute's (Sabin) first ever Phase 1...

Jan 11, 2012, 14:48 ET

IDRI Awarded Additional Funds for Novel TB Drugs

 The Infectious Disease Research Institute (IDRI) announced today the receipt of supplemental funds from the Bill & Melinda Gates...

Dec 21, 2011, 17:56 ET

Human Trials Initiated for New HIV Vaccine

Clade C HIV Envelope Protein Being Tested in Phase I Clinical Trial In the first clinical trial of an injectable vaccine containing...

Dec 07, 2011, 15:11 ET

IDRI Announces New VP Tuberculosis Drug Development

Gail H. Cassell, Ph.D., to join IDRI The Infectious Disease Research Institute (IDRI) announced today that Dr. Gail H. Cassell has...

Nov 29, 2011, 14:11 ET

IDRI to present at India - U.S. Forum

Dr. Christopher Fox to discuss IDRI's technology transfer efforts The Infectious Disease Research Institute (IDRI) announced today that IDRI...

Nov 17, 2011, 08:30 ET

Eli Lilly and Company Provides IDRI with Additional Funding for Identification of New Tuberculosis Therapies

The Infectious Disease Research Institute (IDRI) has been awarded more than $4 million in additional funding over the next four and a half years by...

Oct 17, 2011, 13:33 ET

IDRI Partners With Global Research Initiative ADITEC to Accelerate Human Vaccine Development

The Infectious Disease Research Institute (IDRI) has joined the Advanced Immunization Technologies (ADITEC) program, a collaborative initiative...

Oct 12, 2011, 16:47 ET

The Paul G. Allen Family Foundation Supports Launch of IDRI's TB Vaccine Clinical Program

The Infectious Disease Research Institute (IDRI) has been awarded a two-year $300,000 grant from The Paul G. Allen Family Foundation to support...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets
Analysts Review
ReportBuyer